Gabapentin for substance use disorders: Is it safe and appropriate?

Journal of Psychosocial Nursing and Mental Health Services

Volumn 52, Issue 2, 2014, Pages 13-16

  Howland, Robert H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMINE; ANXIOLYTIC AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; GABAPENTIN;

FOOD AND DRUG ADMINISTRATION; HUMAN; PRESCRIPTION; PRESCRIPTION DRUG MISUSE; SAFETY; STATISTICS AND NUMERICAL DATA; SUBSTANCE WITHDRAWAL SYNDROME; UNITED STATES;

AMINES; ANTI-ANXIETY AGENTS; CYCLOHEXANECARBOXYLIC ACIDS; DRUG PRESCRIPTIONS; GAMMA-AMINOBUTYRIC ACID; HUMANS; PRESCRIPTION DRUG MISUSE; SAFETY; SUBSTANCE WITHDRAWAL SYNDROME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84894287304     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: 10.3928/02793695-20131217-01     Document Type: Article

References (29)

1. Bisaga, A., & Evans, S.M. (2006). The acute effects of gabapentin in combination with alcohol in heavy drinkers. Drug and Alcohol Dependence, 83, 25-32.
2. Bockbrader, H.N., Wesche, D., Miller, R., Chapel, S., Janiczek, N., & Burger, P. (2010). A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clinical Pharmacokinetics, 49, 661-669. doi:10.2165/11536200-000000000-00000
3. Bronstein, A.C., Spyker, D.A., Cantilena, L.R., Jr., Rumack, B.H., & Dart, R.C. (2012). 2011 annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th annual report. Clinical Toxicology, 50, 911-1164. doi:10.3109/ 15563650.2012.746424
4. Centers for Disease Control and Prevention. (2011). Vital signs: Overdoses of prescription opioid pain relievers-United States, 1999- 2008. Morbidity and Mortality Weekly Report, 60, 1487-1492.
5. Comer, S.D., Ashworth, J.B., Foltin, R.W., Johanson, C.E., Zacny, J.P., & Walsh, S.L. (2008). The role of human drug self-administration procedures in the development of medications. Drug and Alcohol Dependence, 96, 1-15. doi:10.1016/j.drugalcdep.2008.03.001
6. Davy, M., Upward, J., Arumugham, T., Twomey, C., Chen, C., & Stier, B. (2013). Cardiac repolarization with gabapentin enacarbil in a randomized, double-blind, placebo-and active-controlled, crossover thorough QT/QTc study in healthy adults. Clinical Therapeutics. Advance online publication. doi:10.1016/j.clinthera.2013.10.011
7. Del Paggio, D. (2005). Psychotropic medication abuse in correctional facilities. Retrieved from http://www.acbhcs.org/Psychopharmacology/2005/ June2005.pdf
8. Dickens, D., Webb, S.D., Antonyuk, S., Giannoudis, A., Owen, A., Rädisch, S., Pirmohamed, M. (2013). Transport of gabapentin by LAT1 (SLC7A5). Biochemical Pharmacology, 85, 1672-1683. doi:10.1016/j.bcp.2013.03.022
9. Dilsaver, S.C. (1988). Antimuscarinic agents as substances of abuse: A review. Journal of Clinical Psychopharmacology, 8, 14-22.
10. Duka, T., Crombag, H.S., & Stephens, D.N. (2011). Experimental medicine in drug addiction: Towards behavioral, cognitive and neurobiological biomarkers. Journal of Psychopharmacology, 25, 1235-1255. doi:10.1177/0269881110388324
11. General Register Office for Scotland. (n.d.). Vital events reference tables. Retrieved from http://www.gro-scotland.gov.uk/statistics/theme/ vital-events/general/ref-tables/index.html
12. Gilron, I., Bailey, J.M., Tu, D., Holden, R.R., Weaver, D.F., & Houlden, R.L. (2005). Morphine, gabapentin, or their combination for neuropathic pain. New England Journal of Medicine, 352, 1324-1334.
13. Haddad, P. (1999). Do antidepressants have any potential to cause addiction? Journal of Psychopharmacology, 13, 300-307.
14. Hilliard, W.T., Barloon, L., Farley, P., Penn, J.V., & Koranek, A. (2013). Bupropion diversion and misuse in the correctional facility. Journal of Correctional Health Care, 19, 211-217. doi:10.1177/1078345813486448
15. Howland, R.H. (2013). Gabapentin for the treatment of substance use disorders. Journal of Psychosocial Nursing and Mental Health Services, 51(12), 11-14. doi:10.3928/02793695- 20131120-01
16. Howland, R.H. (2014). Gabapentin: Can it be misused? Journal of Psychosocial Nursing and Mental Health Services, 52(1), 12-15. doi:10.3928/02793695-20131213-01
17. Keskinbora, K., Pekel, A.F., & Aydinli, I. (2007). Gabapentin and an opioid combination versus opioid alone for the management of neuropathic cancer pain: A randomized open trial. Journal of Pain and Symptom Management, 34, 183-189.
18. Klein-Schwartz, W., Shepherd, J.G., Gorman, S., & Dahl, B. (2003). Characterization of gabapentin overdose using a poison center case series. Journal of Toxicology and Clinical Toxicology, 41, 11-15.
19. Lintzeris, N., & Nielsen, S. (2009). Benzodiazepines, methadone, and buprenorphine: Interactions and clinical management. American Journal on Addictions, 19, 59-72. doi:10.1111/ j.1521-0391.2009.00007.x
20. Medicines and Healthcare Products Regulatory Agency. (n.d.). Download drug analysis prints (DAPs). Retrieved from http://www.mhra.gov.uk/Safetyinformation/Howwemonitorthesafetyofproducts/Medicines/TheYellowCardScheme/YellowCarddata/Druganalysisprints/index.htm
21. Middleton, O. (2011). Suicide by gabapentin overdose. Journal of Forensic Science, 56, 1373-1375. doi:10.1111/j.1556-4029.2011.01798.x
22. Myrick, H., Anton, R., Voronin, K., Wang, W., & Henderson, S. (2007). A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm. Alcoholism, Clinical and Experimental Research, 31, 221-227.
23. Paulozzi, L.J. (2012). Prescription drug overdoses: A review. Journal of Safety Research, 43, 283-289. doi:10.1016/j.jsr.2012.08.009
24. Sansone, R.A., & Sansone, L.A. (2010). Is seroquel developing an illicit reputation for misuse/abuse? Psychiatry (Edgmont), 7, 13-16.
25. Schauer, S.G., & Varney, S.M. (2013). Gabapentin overdose in a military beneficiary. Military Medicine, 178, e133-e135. doi:10.7205/ MILMED-D-12-00301
26. Scottish Crime and Drug Enforcement Agency. (2012). Report on the quality of diamorphine seized in Scotland 2010-2011. Retrieved from http://www.knowledge.scot.nhs.uk/media/CLT/ ResourceUploads/4010771/2012-03-28%20 diamorpine%20purity%20report%20FINAL.pdf
27. Smith, B.H., Higgins, C., Baldacchino, A., Kidd, B., & Bannister, J. (2012). Substance misuse of gabapentin. British Journal of General Practice, 62, 406-407. doi:10.3399/bjgp12X653516
28. Substance Abuse and Mental Health Services Administration. (n.d.) Drug Abuse Warning Network. Retrieved from http://www.samhsa.gov/data/DAWN.aspx
29. Thomas, A., Nallur, D.G., Jones, N., & Deslandes, P.N. (2009). Diphenhydramine abuse and detoxification: A brief review and case report. Journal of Psychopharmacology, 23, 101-105. doi:10.1177/0269881107083809